UBS Group AG - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 107 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is 5.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$41,157
+15.7%
50,811
+0.0%
0.00%
Q1 2023$35,560
+6160.6%
50,800
+6250.0%
0.00%
Q4 2022$568
-95.6%
800
-90.9%
0.00%
Q3 2022$13,000
-70.5%
8,813
-79.8%
0.00%
Q2 2022$44,000
+633.3%
43,593
+1004.2%
0.00%
Q1 2022$6,000
-91.9%
3,948
-72.3%
0.00%
Q4 2021$74,000
+428.6%
14,232
+470.4%
0.00%
Q3 2021$14,000
-72.5%
2,495
-60.7%
0.00%
Q2 2021$51,000
-65.5%
6,342
-64.4%
0.00%
Q1 2021$148,000
+11.3%
17,817
+1.8%
0.00%
Q4 2020$133,000
+41.5%
17,494
+98.6%
0.00%
Q3 2020$94,000
-92.7%
8,808
-89.7%
0.00%
-100.0%
Q2 2020$1,292,000
-23.0%
85,213
-57.7%
0.00%0.0%
Q1 2020$1,678,000
-52.1%
201,414
-2.9%
0.00%0.0%
Q4 2019$3,505,000
+16.5%
207,367
+28.0%
0.00%0.0%
Q3 2019$3,008,000
-25.4%
161,947
-8.1%
0.00%
-50.0%
Q2 2019$4,030,000
+11.9%
176,160
+2.9%
0.00%
+100.0%
Q1 2019$3,600,000
+53.1%
171,267
-16.2%
0.00%0.0%
Q4 2018$2,351,000
-47.7%
204,465
+4.4%
0.00%
-50.0%
Q3 2018$4,492,000
+8.8%
195,755
+5.7%
0.00%0.0%
Q2 2018$4,130,000
+5.8%
185,168
+8.4%
0.00%0.0%
Q1 2018$3,903,000
-21.2%
170,840
-9.6%
0.00%0.0%
Q4 2017$4,950,000
+23.7%
188,921
+5.9%
0.00%0.0%
Q3 2017$4,003,000
-11.4%
178,322
+8.0%
0.00%0.0%
Q2 2017$4,517,000
+28.8%
165,154
+14.0%
0.00%0.0%
Q1 2017$3,506,000
+24.4%
144,867
+6.6%
0.00%0.0%
Q4 2016$2,819,000
-25.8%
135,882
-2.4%
0.00%0.0%
Q3 2016$3,797,000
+105.7%
139,278
+8.6%
0.00%
+100.0%
Q2 2016$1,846,000
+1.9%
128,289
+1.7%
0.00%0.0%
Q1 2016$1,812,000
-49.7%
126,087
-24.7%
0.00%
-66.7%
Q4 2015$3,600,000
+162.0%
167,513
+97.2%
0.00%
+200.0%
Q3 2015$1,374,000
-36.0%
84,966
+2.1%
0.00%0.0%
Q2 2015$2,148,000
+4.6%
83,231
-8.8%
0.00%0.0%
Q1 2015$2,054,000
+12.8%
91,277
-3.8%
0.00%0.0%
Q4 2014$1,821,00094,8860.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders